bioRxivBioengineeringPreprint
Microfluidic T-Chip enables one-step clinical-scale T-cell purification from blood products for CAR T-cell manufacturing
Maheen RanaiD, Sophia E. NigroviciD, Adriana Payan-MedinaiD, Sarthak SahaiD, Victor R. PutaturoiD, Quinn E. CunneelyiD, Remy BelliD, Ezgi AntmeniD, Marcela Valderrama MausiD, Mehmet ToneriD, Magdi ElsallabiD, Avanish MishraiD
Abstract
Treatment with chimeric antigen receptor (CAR) T cells has emerged as a promising immune therapy for relapsed and refractory hematologic malignancies. The CAR T cells are manufactured in a series of steps that involve isolating T cells from the patients leukapheresis product, genetically modifying them to express the CAR against the target antigen, and reinfusing them into the patient. Efficient T-cell enrichment from leukapheresis products is critical to the success of these therapies. Current methods for T-cell sorting on a clinical scale involve several washing steps to remove red blood cells and platelets, followed by T-cell selection and activation. These multi-step processes result in cell loss during processing and involve several handling steps. Here, we utilize fluidically assembled micromagnetic lenses to develop a high-throughput, continuous-flow microfluidic T-cell sorter, designated as the T-Chip, for sorting magnetic bead-labeled CD3+ T cells in a single step. Our approach allows direct sorting of T cells in expansion media from leukopaks without any washing steps, effectively removing 99.999% of RBCs and platelets from the leukapheresis product. A single 1-inch x 3-inch T-Chip can process leukapheresis product at a throughput of 60 mL/hr and 2.56 {+/-} 0.12 billion cells/hr. Using this optimized workflow, we demonstrate clinical-scale enrichment of highly pure CD3+ T cells (97.7 {+/-} 1.3%) with high viability (97.0 {+/-} 1.1%) and recovery (87.3 {+/-} 14.8%) in a functionally closed manner. Downstream processing of T cells isolated using the T-Chip yielded potent anti-mesothelin CAR T cells with demonstrated anti-tumor efficacy. Overall, by exploiting precisely engineered magnetic forces and laminar flow, the microfluidic T-Chip overcomes bottlenecks caused by low throughput and enables single-step large-scale T-cell purification for the rapid development of CAR T cells.
- organism: human
- assay: flow cytometry
- research focus: cell type annotation
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Development of Ingenui-T, a Novel Vein-to-Vein Solution for Rapid Autologous CAR T-Cell Manufacturing Starting From Whole Blood, for the Treatment of Autoimmune Diseases
- High-density microbioreactor process designed for automated point-of-care manufacturing of CAR T cells
W.-X. Sin, N. S. Jagannathan, … M. E. Birnbaum·bioRxiv·Apr 7, 2023
- Scalable intracellular delivery via microfluidic vortex shedding enhances the function of chimeric antigen receptor T-cells
Brandon J. Sytsma, Vincent Allain, … Ryan S. Pawell·Scientific ReportsPeer-reviewed·Feb 17, 2025
- Functionalized microcarriers improve T cell manufacturing by facilitating migratory memory T cell production and increasing CD4/CD8 ratio
N. J. Dwarshuis, H. W. Song, … K. Roy·bioRxiv·May 23, 2019
- Leucine zipper-based sorting system enables generation of multi-functional CAR T cells
Scott E. James, Sophia Chen, … Marcel R.M. van den Brink·bioRxiv·Sep 13, 2023
- Hydrodynamic shear enables enrichment of functional tumor antigen-reactive T cells
Prem Santhosh Subramanian, Michelle Fu, … Venktesh S. Shirure·bioRxiv·Jul 8, 2026